Lack of complete information regarding the histological examination, pre-operative Tg, presence of lymph node metastasis, history of RAI therapy, and total RAI dose were drawbacks that excluded several patients from our analysis, reducing the final study population. This evidence concerns the gene TG and metastatic malignant neoplasm in the lymph nodes.